New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Lantern Pharma Inc. (LTRN) vs Pulmatrix, Inc. (PULM)
- Lantern Pharma Inc. LTRN 0.28 −15.15%
- Pulmatrix, Inc. PULM 1.40 +4.48%
Lantern Pharma Inc. and Pulmatrix, Inc. are both Biotechnology companies. Lantern Pharma Inc. and Pulmatrix, Inc. are of similar size ($4.9M and $4.9M). Across the 9 metrics below, Pulmatrix, Inc. leads on 7 and Lantern Pharma Inc. on 2.
Valuation
Profitability
| Metric | LTRN | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (250.59%) | (172.27%) | (51.58%) |
| Return on assets | (124.41%) | (119.43%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack